The association between irAE development and ICOS+CD4+ T cells was forecasted in a previous study demonstrating that increased frequency of peripheral ICOS+CD4+ T cells was ameliorated by steroid treatment in patients with immune-related hepatitis and encephalomyelitis (37). This evidence concerns the gene CD4 and encephalomyelitis.